Delivery Order SPE2DB22D3301-SPE2DB24FY7ND
- Not listed
- This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract, valued at $4,809.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Department of Defense (DoD) agency, and has a completion date of July 2, 2024. The contract is a Delivery Order on a Firm Fixed Price basis, with no set-aside designation. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 5 GRAM/50 ML VIAL 50ML. The contract has a ceiling value of $5,918.60 and is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML to the Defense Logistics Agency (DLA), a defense agency. The $14,295.00 firm-fixed price delivery order contract has a period of performance through May 10, 2024 and was awarded on April 19, 2024. This contract is not set aside for any special designation. Amerisourcebergen, a major pharmaceutical distribution company,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the drug GAMUNEX-C 20 gram/200 ml vial. The $7,394.46 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $42,885 for the supply of 4,565,476,984 units of the pharmaceutical product GAMUNEX-C, a 20 gram/200 ml vial. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency customer of Amerisourcebergen. This contract does not have a set-aside designation. Amerisourcebergen is a leading pharmaceutical distributor that holds several Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract, valued at $9,618.16, is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA). It has an ultimate completion date of June 26, 2024. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, worth $14,427.24, is a delivery order for the supply of GAMUNEX-C 40 gram/400 ML vials. The contract has a firm fixed price and an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $26,849.76 and is a Firm Fixed Price Delivery Order for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This federal contract award is for the procurement of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML by the Defense agency Medical Supply Chain. The $3,606.84 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product GAMUNEX-C, a 10 gram/100 ml vial. The award is valued at $7,462.92 and has a firm fixed price pricing type with a period of performance through January 9, 2025. The contract does not have a set-aside designation, indicating...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY7NDDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $4,808.80 for the delivery of the pharmaceutical product GAMUNEX-C 1 GRAM/10 ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA in support of the Department of Defense's global military treatment programs and facilities. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 5/29/24 |